Tag: Quintiles
IQVIA named to FORTUNE Mag’s 2020 list of world’s most admired...
IQVIA has got recognized in FORTUNE’s Healthcare: Pharmacy and Other Services category with high marks regarding efficient use of corporate assets, management quality, effectiveness in conducting business globally, and long-term investment value.................
“Human data science is our revolutionary new way to drive healthcare...
In an exclusive interview with Mr Naz Haji, Managing Director, IQVIA India, the Biovoice News tried to understand the logic behind renaming, fresh priorities of the company and its focus on human data science. Read the interesting details..............
IQVIA named to FORTUNE’s 2018 list of “world’s most admired companies”
The company was featured in the FORTUNE’s 'Healthcare: Pharmacy and Other Services' category with high marks in quality of management, value as a long-term investment, effectiveness in conducting business globally and wise use of corporate assets.........
QuintilesIMS renames itself as IQVIA
It fuels the company’s approach to human data science, including faster, more predictable clinical development, innovative approaches to generating real-world evidence, machine learning to improve patient care................
“The worst is over for clinical research industry”
Having witnessed the loss of fortunes in near past, the Indian clinical research industry has regained its poise and is set towards much positive outlook, writes Naz Haji...........
QuintilesIMS: Merger creates global integrated IT-enabled healthcare service provider
IMS Health merged into Quintiles with Quintiles as the surviving company renamed Quintiles IMS Holdings, Inc. and known as QuintilesIMS...
Quintiles, DaVita Clinical Research enter into strategic alliance
DaVita Clinical Research brings to this alliance data-driven trial feasibility expertise, trial sites in Europe and Latin America, its deep.....
Quintiles welcomes DCGI’s revised rules on clinical trials
In a statement, one of the leading global players in clinical research has appreciated the move by the Drugs Controller General.....
Race for 7: Bangalore runs to raise voice of rare disease...
Matching strides with those of rare disease patients, a few thousand Bangaloreans participated in Race for 7, a unique....
With positive trends in 2016, biosimilar wave continues
About Author:
Dr Charu Manaktala, Senior Medical Director & Head of Clinical Strategy, Strategic Drug Development, Quintiles Asia.
Biologics with patents expiring between 2015 and 2020...